MRIS Inc. (NASDAQ: IMRS) today announced that a recently published article in the journal Neurosurgery is the highest level clinical ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE